Antiverse, a biotechnology company developing a computational antibody drug discovery platform, today announced a partnership with a top 20 pharma company with core competencies in the life science fields of health care and nutrition. The collaboration has been successful in identifying antibody candidates for a target of interest, with greater diversity (2.3x) and accuracy compared […]
The post Antiverse collaborates with a top 20 pharma company to identify antibody drug candidates using AI Augmented Drug Discovery platform appeared first on .
